US FDA Grants Emergency Use Authorisation To Regeneron Covid-19 Antibody Given To Trump


2020-11-22 | By malaymail | 49 Hits

The Regeneron Pharmaceuticals company logo is seen on a building at the companys Westchester campus in Tarrytown New York US September 17 2020 Reuters picNOV 21 The US Food and Drug Administration yesterday issued emergency use authorisation for Regeneron Pharmaceuticals Incs Covid19 antibody therapy an experimental treatment given to US President Donald Trump that he said helped cure him of the diseaseThe FDA said the monoclonal antibodies casirivimab and imdevimab should be administered together for the treatment of mild to moderat >>READ MORE

ViRealHUB.com | Organic and Viral Social Traffic Hub



Website Online Counter